ArticleTherapeutic advances in chronic disease2010

The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease.

Anthony O'Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.